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Introduction
The Nup107–160 complex (Nup107 complex) is an evolution-
arily conserved nucleoporin subcomplex that plays a crucial 
role in nuclear pore complex (NPC) assembly, mRNA export, 
and cell differentiation (Boehmer et al., 2003; Harel et al., 2003; 
Walther et al., 2003; González-Aguilera and Askjaer, 2012). 
A small fraction of the Nup107 complex localizes to kineto-
chores from early prophase to late anaphase (Belgareh et al., 
2001). Efficient depletion of the Nup107 complex component 
Seh1 from mammalian cells causes chromosome alignment 
and segregation defects (Zuccolo et al., 2007) by altering the 
centromeric localization of the chromosomal passenger com-
plex (Platani et al., 2009).
During mitosis, a signaling network involving the kinases 
Aurora A, Polo-like kinase 1 (Plk1), and CDK1/Cyclin B and 
their counteracting phosphatases controls the localization and 
function of various components of the mitotic spindle (Carmena 
et al., 2009; Rieder, 2011). Aurora A kinase localizes on centro-
somes and spindle pole microtubules from late S phase through-
out mitosis, where it plays a role in mitotic entry, centrosome 
maturation and separation, and bipolar spindle formation and 
function (Barr and Gergely, 2007; Carmena et al., 2009; Ho-
chegger et al., 2013). Aurora A substrates include TPX2 (Kufer 
et al., 2002), TACC3 (Giet et al., 2002; Barros et al., 2005), 
Ajuba (Hirota et al., 2003), Eg5 (Giet et al., 1999), and HURP 
(Yu et al., 2005; Wong et al., 2008).
Plk1 is a critical regulator of mitosis that regulates cen-
trosome maturation, kinetochore–microtubule attachment, and 
cleavage furrow ingression (Petronczki et al., 2008; Bruinsma 
et al., 2012; Zitouni et al., 2014). Spindle pole localization of 
Plk1 controls recruitment of pericentrin and γ-tubulin com-
plexes to centrosomes (Lane and Nigg, 1996; Casenghi et al., 
2003; Lee and Rhee, 2011) and has also been implicated in 
centrosome disjunction and separation (Bruinsma et al., 2012). 
Centrosomal Plk1 additionally controls spindle positioning and 
orientation by regulating binding of the dynein–dynactin com-
plex to its cortical targeting factors Numa and LGN (Kiyomitsu 
and Cheeseman, 2012). During prometaphase, Plk1 localiza-
tion at kinetochores is required for chromosome alignment and 
faithful chromosome segregation (Elowe et al., 2007; Liu et 
al., 2012; Maia et al., 2012).
Mitotic activity of Aurora A and Plk1 kinases is controlled 
by a balance of phosphorylation and dephosphorylation in time 
and space. Aurora A activation depends on the autophosphory-
lation of Thr288 in its activation loop, which occurs primarily at 
centrosomes (Littlepage et al., 2002; Zorba et al., 2014) and on 
TPX2-mediated localization and activation on spindle microtu-
bules (Kufer et al., 2002; Bayliss et al., 2003; Eyers and Maller, 
2003, 2004; Tsai et al., 2003). Aurora A/Bora activates Plk1 at 
centrosomes in late G2/prophase via phosphorylation of its ac-
tivation loop at Thr210 (Macůrek et al., 2008; Seki et al., 2008).
Coordination of cell growth and proliferation in response to nutrient supply is mediated by mammalian target of rapa-
mycin (mTOR) signaling. In this study, we report that Mio, a highly conserved member of the SEACAT/GATOR2 complex 
necessary for the activation of mTORC1 kinase, plays a critical role in mitotic spindle formation and subsequent chro-
mosome segregation by regulating the proper concentration of active key mitotic kinases Plk1 and Aurora A at centro-
somes and spindle poles. Mio-depleted cells showed reduced activation of Plk1 and Aurora A kinase at spindle poles 
and an impaired localization of MCAK and HURP, two key regulators of mitotic spindle formation and known substrates 
of Aurora A kinase, resulting in spindle assembly and cytokinesis defects. Our results indicate that a major function of 
Mio in mitosis is to regulate the activation/deactivation of Plk1 and Aurora A, possibly by linking them to mTOR signal-
ing in a pathway to promote faithful mitotic progression.
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Mammalian target of rapamycin (mTOR) is a serine/thre-
onine protein kinase involved in cell proliferation, cell size reg-
ulation, transcription, and cytoskeletal regulation in response 
to a variety of input signals (Harris and Lawrence, 2003; Ja-
cinto and Hall, 2003; Wullschleger et al., 2006). Two mTOR 
complexes have been identified in mammalian cells mTORC1 
and mTORC2 (Guertin and Sabatini, 2007). The mTORC1 
complex contains the regulatory protein raptor and, by regu-
lating the phosphorylation of p70S6 kinase and 4E-binding 
protein 1 (4EBP1), controls their downstream functions in pro-
tein translation, cell growth, and cell proliferation (Loewith et 
al., 2002). mTORC2 contains the regulatory subunit rictor and 
is involved in regulation of the actin cytoskeleton (Jacinto et 
al., 2004). Almost all documented mTOR functions take place 
during interphase, although the mTORC1 complex has been 
implicated in mitotic entry in fission yeast through the stress 
MAPK pathway (Petersen and Nurse, 2007). mTORC1 ac-
tivation requires Rag-GTPases, two regulators of which have 
recently been identified: the SEACAT/GATOR1 and 2 subcom-
plexes (Panchaud et al., 2013b).
Here, we have identified a mitotic role for Mio, a highly 
conserved member of the SEACAT/GATOR2 complex, which 
regulates Rag-1 and mTOR signaling (Bar-Peled et al., 2013; 
Panchaud et al., 2013a). We show that Mio is required for spin-
dle formation and subsequent chromosome segregation and for 
the proper concentration of active Plk1 and Aurora A kinases 
at centrosomes and spindle poles. Our results suggest that Mio 
may regulate the activation/deactivation of Plk1 and Aurora A, 
possibly by linking them to mTOR signaling in a pathway that 
promotes faithful mitotic progression.
Results
Nucleoporin Seh1 interacts with Mio, 
WDR24, and WDR59, components of the 
SEACAT/GATOR2 complex, in 
mammalian cells
Seh1 is a member of the Nup107 complex that functions in NPC 
assembly and localizes to kinetochores in mitosis (Belgareh et 
al., 2001). To better define its biochemical interactions in mam-
malian cells, we isolated GFP-Seh1 both from asynchronous 
and mitotically arrested HeLaGFPSeh1 cells (Platani et al., 2009) 
and identified interacting proteins by SILAC (stable isotope la-
beling by amino acids in cell culture) mass spectrometry (Ong 
and Mann, 2007). This analysis identified all known Seh1-in-
teracting proteins, including components of the Nup107 com-
plex (Nup107, 98, 133, 160, and 85) and SEACAT/GATOR2 
complexes (Mios, WDR24, and WDR59; Fig. 1 A and Fig. 
S1 A; Dokudovskaya et al., 2011; Bar-Peled et al., 2013; 
Panchaud et al., 2013a). Interestingly, Seh1 interacts with the 
SEACAT/GATOR2 complex equally in interphase and mitosis, 
whereas its interaction with the rest of the Nup107 complex 
is stronger during mitosis.
We confirmed the Mio–Seh1 interaction using recombi-
nant mCherry-Mio expressed in mammalian cells. Seh1 coim-
munoprecipitated with mCherry-Mio protein but not with the 
mCherry control (Fig. 1 B). Furthermore, levels of endogenous 
Mio protein were reduced in HeLa cells upon Seh1 depletion 
(Fig. 1 C). Because Seh1 overexpression does not increase 
Mio protein levels (Senger et al., 2011), this suggests that Seh1 
promotes Mio’s stability in mammalian cells. Although Seh1 
is a nucleoporin, depletion of Mio resulted in no detectable 
changes in NPC structure or assembly that could be detected 
by mAb414 staining against FG repeat nucleoporins. The nu-
clear rim localization of endogenous Seh1 also appeared not 
to be affected (Fig. S1 B).
Mio depletion causes mitotic defects
Having previously described a requirement for Seh1 for mitotic 
progression (Platani et al., 2009), we next explored the role of 
Mio in mitotic spindle assembly and chromosome segregation. 
RNAi depletion of Mio resulted in an increase in the number 
of binucleate cells, micronucleation, and aberrant nuclear mor-
phology with a variety of different oligos against Mio (Fig. 1, 
D and E; and see the following paragraphs). To better define 
the Mio depletion phenotype in living cells, we used time-
lapse phase-contrast microscopy. Cells transfected with control 
siRNA underwent mitosis with normal timing, and cytokinesis 
was completed within 2 h followed by a period in interphase 
(Fig. 1 F). Apoptotic events were rarely seen (1.6%), indicat-
ing that phototoxicity is minimal under our imaging condi-
tions. Mio-depleted cells remained in mitosis and cytokinesis 
for extended periods of time before either furrow ingression 
resulted in binucleation, a period in interphase, or apoptosis 
(which was observed both during mitosis and interphase; Fig. 
1 F). Mio is therefore required for normal mitotic progression. 
Interestingly, Mio depletion did not result in an increase in the 
fraction of cells in mitosis (Fig. 2 A). Therefore, the increased 
time that cells spend in mitosis must be counterbalanced by a 
decrease in mitotic entry.
More detailed live cell imaging of cells stably expressing 
mRFP-H2B and EGFP–α-tubulin or EGFP-H2B alone revealed 
that the kinetics of bipolar spindle formation was abnormal in 
Mio-depleted cells, although chromosomes eventually aligned 
on what appeared to be a metaphase plate (Fig. 2 B and Fig. 
S2 D). Phenotypic analysis of mitotic progression in Mio-de-
pleted cultures showed an increase in prometaphase cells (from 
13 to 28%; Fig. 2 C) with spindles often in closer proximity 
to one side of the cell. During mitotic exit, chromosome seg-
regation defects, including increased chromatin bridges and 
micronucleation, were observed (Fig. 2 D). Cytokinesis also 
appeared to be delayed (the percentage of cells in cytokinesis 
increased from 26 to 37%; Fig. 2 C). In 6.9% of cells, no furrow 
ingression was observed followed by either fusion of chromatin 
masses or production of binucleate cells (the latter increased 
twofold relative to control-depleted cells; Fig. 2 E). Whereas 
control cells progressed to anaphase soon after metaphase chro-
mosome alignment (31.35 ± 5.2 min), Mio depletion resulted 
in a prolongation of the period from nuclear envelope break-
down (NEBD) to anaphase onset (40.5 ± 9.4 min; Fig. 2 F). 
In addition, Mio-depleted cells showed an uneven timing of 
daughter cell adhesion to the substratum (Fig. 2 G), a charac-
teristic of uneven cell division, as orientation of the cell divi-
sion plane is controlled by the orientation of the mitotic spindle 
relative to the cell cortex.
Mio depletion results in spindle and 
centrosomal defects
The previous observations suggested a potential defect in spin-
dle formation and/or chromosome capture after Mio depletion. 
However, Mio-depleted cells displayed no obvious defects in 
kinetochore–microtubule interactions, checkpoint proteins, 
or checkpoint bypass, at least as reported by Bub1 and Sgo1 
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Figure 1. Seh1 interacts with the SEACAT complex both in interphase and mitosis. (A) Seh1 complexes were purified from a cell line stably expressing 
GFP-Seh1, HeLaEGP-SEH1. Cells were differentially labeled with isotopic amino acids by growth in SILAC media before immunopurification of GFP-Seh1 
complexes. Where indicated, cells were arrested in mitosis using 200 ng/ml nocodazole for 14 h. Immunopurified GFP-Seh1 complexes were analyzed 
by quantitative mass spectrometry. Plot of log ratio H/M versus relative abundance (summarized peptide intensities normalized by molecular weight) for all 
quantified proteins is shown. Bait protein GFP-Seh1 (green circles) and the interactors Nup107 complex (purple diamonds) and SEACAT/GATOR2 complex 
(blue diamonds) are highlighted. This nonbiased quantitative experiment was performed twice in asynchronous cell populations and once in mitotically 
arrested cells, and top hits were chosen for targeted follow-up validation by immunoprecipitation/Western blot analysis using specific antibodies. (B) Mio 
interacts with Seh1 in mammalian cells. Immunoprecipitates (IP) are shown of total protein extracts from HeLa cells transfected with mCherry, mCherry-Mio, 
and EGFP-Seh1. Immunoprecipitation was performed using α-RFP binder, and Seh1 was detected using α-Seh1 antibody. (C) Immunoblots of HeLa cell 
lysates treated with siRNAs corresponding to negative control and Seh1 (probed using α-Mio and α-Seh1) show that depletion of Seh1 can affect Mio sta-
bility. (D) Immunoblots of HeLa cell lysates treated with siRNAs corresponding to negative control and Mio (probed using α-Mio) show efficient depletion of 
Mio protein with different siRNA oligos 48 h after transfection. (C and D) Tubulin served as a loading control. (E) Abnormal nuclear morphology detected 
after Mio depletion. HeLa cells transfected with control and Mio siRNA oligos for 48 h were stained with DAPI to reveal the DNA and nuclear morphology. 
(F) Mio depletion increases mitotic length, binucleation, and apoptosis. HeLa cells transfected with control or Mio siRNAs were incubated for 30 h before 
phase-contrast imaging for a further 19 h. Images were acquired every 15 min. Image sequences were then analyzed tracking individual control (n = 
132) and Mio-depleted cells (n = 289) to determine their behavior. Fate profiles of live control or Mio-depleted cells are shown as a function of time. Bars 
represent total time spent at different cell cycle stages for individual cells. Starting point T = 0 is NEBD. Bar, 10 µm.
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staining and the ability of cells to undergo mitotic arrest in 
nocodazole (Fig. S2, A–C). We therefore looked in detail at 
centrosome-mediated spindle formation.
Closer inspection of the distribution of α-tubulin and 
the centrosomal markers γ-tubulin and pericentrin in Mio-de-
pleted cells revealed an increase in several spindle defects. 
Figure 2. Mio is required for mitotic progression. (A) Mitotic index of control (blue bar) and Mio-depleted cells (red bar) 48 h after transfection (n = 3). 
(B) Depletion of Mio causes spindle assembly and cytokinesis defects. Selected maximum intensity projections from time-lapse images show the mitotic and 
cytokinesis defects. HeLa cell line stably expressing EGFP-tubulin (green) and mRFP-H2B (red), HeLaEGFPTubulin-mRFPH2B, was transfected with Mio siRNA oligos. 
Images were collected every 5 min at 46 h for a period of 120 min. Numbers indicate time in hours/minutes/seconds. (C) Quantitation of different mitotic 
stages for control (blue bars) and Mio-depleted cells (red bars; n = 3). (D) Quantitation of micronucleation and chromatin bridges in control and Mio-de-
pleted cells. Error bars represent SD. (E) Binucleation index of control (blue bar) and Mio-depleted cells (red bar) 48 h after transfection (n = 3). (F) Mitotic 
progression scatter plots of anaphase onset with NEBD as T = 0 in control (blue) and Mio siRNA-treated cells (red) from live cell videos. Statistical signifi-
cance was determined by a two-tailed, unpaired t test. (G) Quantitation of normal and misoriented cell divisions in cells treated as in B (n = 3). Bar, 10 µm.
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These included abnormal tilt of the spindle axis, disrupted or 
unfocused spindle poles, monopolar spindles, displacement 
of the spindle from the cell center toward the cell cortex, and 
failure of centrosomes to localize at both spindle poles (Fig. 
3 A). Most depleted cells showed one or a combination of the 
aforementioned phenotypes.
To measure the orientation of the mitotic spindle in re-
lation to the substratum, 3D image stacks were acquired for 
Mio-depleted cells grown on fibronectin-coated coverslips. In 
control RNAi cells grown on these coverslips, the metaphase 
spindle axis tends to align parallel to the substratum. Although 
spindle length was normal in Mio-depleted cells (Fig. 3 B), the 
spindle azimuth, as judged by the metaphase angle α, was sig-
nificantly increased (Fig. 3, C and D). In addition, Mio-depleted 
cells showed an increase in bipolar, monoastral spindles, with 
one pole lacking γ-tubulin or pericentrin (Fig. 3 E).
To allow a quantitative measurement of spindle assem-
bly and chromosome alignment, we examined the recovery of 
Mio-depleted cells from Monastrol, a kinesin Eg5 inhibitor that 
arrests mitotic cells in prometaphase with monopolar spindles 
Figure 3. Mio depletion leads to spindle misorienta-
tion and centrosomal defects. (A) Abnormal spindle 
morphology detected after Mio depletion. HeLa cells 
were transfected with control and Mio siRNA oligos 
for 48 h and stained with α-tubulin. (B) Quantification 
of metaphase spindle length between control (blue) 
and Mio-depleted cells (red) shows no significant 
change in the length of the mitotic spindle. (C) Sche-
matic depicting the spindle angle (α) measurement rel-
ative to the fibronectin substratum. (D) Quantification 
of metaphase spindle angles between control (blue) 
and Mio-depleted cells (red) showing a significant in-
crease of >20o of spindle angle. n = 40 from three 
experiments. (E) Quantification of mitotic metaphase 
cells with an unequal number of centrosomes and 
spindle poles. 3D maximum intensity projections 
of representative metaphase cells immunostained 
with α-pericentrin (green), α-tubulin (red), and DNA 
(blue) are shown on the right. 300 cells per con-
dition (n = 3). Bars, 10 µm.
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without affecting microtubule dynamics (Kapoor et al., 2000). 
At 30 min after Monastrol washout, control mitotic cells had 
rapidly formed a bipolar spindle, with only 40% of cells still 
having a disorganized spindle. In contrast, at 30 min after 
Monastrol washout, Mio-depleted cells had a pronounced delay 
in bipolar spindle formation, with 76% of cells having monop-
olar or incomplete bipolar spindles (Fig. 4).
Micronuclei and lagging chromosomes can occur as a re-
sult of kinetochore–microtubule misattachments, either due to 
defects in error correction mechanisms, microtubule dynamics, 
or spindle formation. After observing defects in spindle forma-
tion and micronuclei in Mio-depleted cells, we decided to look 
at kinetochore–microtubule attachments in detail. We observed 
no changes in Survivin or Aurora B levels at centromeres of 
Mio-depleted cells (Fig. S3, A and B), and cold-stable kineto-
chore fibers were also present, suggesting that the kinetochore 
attachment site is not disrupted (Fig. S3 C).
Plk1 and Aurora A are misregulated after 
Mio depletion
To characterize the mechanism underlying the various de-
fects in Mio-depleted mitotic cells, we focused on Plk1 and 
Aurora A. Both of these mitotic kinases have numerous 
important roles in spindle formation and centrosome sep-
aration (Lens et al., 2010).
Limiting titration of the specific Plk1 inhibitor BI2356 
revealed a synthetic interaction with Mio depletion. In Mio-de-
pleted cells, lower concentrations of BI2536 caused a synergis-
tic increase in the percentage of cells with monopolar spindles 
relative to the same drug treatment of control RNAi cells (Fig. 5, 
Figure 4. Bipolar spindle formation is delayed in Mio-depleted cells. (A) Control and Mio-depleted cells were arrested with Eg5 inhibitor Monastrol for 
3 h. The drug was washed out with fresh medium, and cells were fixed at the indicated time points. Cells were immunostained with α-tubulin (red) and 
α-ACA (green). (B) Quantitation of spindle and chromosome alignment status in control and Mio-depleted cells at the indicated time points after Monastrol 
release. 300 cells/time point (n = 3). Bar, 10 µm.
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A–C). Thus, cells depleted of Mio assembled monopolar spin-
dles at concentrations of the drug that did not appreciably affect 
cells after the control RNAi. This was seen most clearly in Fig. 
5 B, which plots Δ, the difference in the percentage of monop-
olar spindles after drug treatments with or without Mio RNAi. 
A positive slope of Δ indicates a synthetic response, whereas 
a horizontal line indicates no increase in drug sensitivity after 
Mio RNAi. It is important to note that after an initial strong 
synthetic response, the Δ curve for Plk1 inhibition decreases 
because both the control and Mio-depleted samples are ap-
proaching a limit of 90% monopolar cells.
Limiting titration of the Aurora A inhibitor MLN8237 
also showed a significant, albeit weaker, synthetic interaction 
(Fig. 5, A, B, and D). In contrast, ZM447439 treatment re-
sulted in an almost horizontal line for Δ, as both control and 
Mio-depleted cells responded to the Aurora B inhibition with 
the same efficiency over the range of ZM447439 concentrations 
tested (Fig. 5, A, B, and E).
Depletion of Mio had significant effects on the activation 
of Aurora A and Plk1 at centrosomes. For example, although we 
observed no changes in total Aurora A localization or the amount 
on centrosomes and spindles (Fig. 6 A), the level of active Au-
rora A (Aurora AT288ph, which is phosphorylated at Thr288 on 
the activation loop) on centrosomes was significantly lower in 
Mio-depleted cells than in RNAi control cells (Fig. 6, B and D). 
We confirmed this by immunoblotting (Fig. 6 G). Rescue exper-
iments on HeLa si02ResGFP-Mio cells, where the endogenous 
Mio was depleted using si02, rescued the prometaphase delay 
phenotype and restored Aurora AT288ph levels at spindle poles 
(Fig. S1, C–E). Depletion of all Mio using si01 gave the ex-
pected prometaphase delay and reduced Aurora AT288ph signal.
Protein phosphatase 6 regulates mitotic spindle formation 
by controlling the T loop phosphorylation of Aurora A bound 
to its activator TPX2 (Zeng et al., 2010). Thus, PPP6C deple-
tion would enhance Aurora A activity and potentially restore 
the mitotic function of Mio-depleted cells. Indeed, co-depletion 
of Mio and PPP6C (catalytic subunit; see Fig. 10 C) rescued 
the prometaphase delay phenotype and restored Aurora AT288ph 
levels at spindle poles (see Fig. 10, A and B).
Plk1 localization and activity also showed a strong re-
sponse to Mio depletion. Centrosomal levels of both total Plk1 
and active PLK1T210ph were reduced (Fig. 6, C and E; and Fig. 
S5 C). In contrast, Plk1 localization to centrosomes and ki-
netochores was not affected (Fig. 6 C). In immunoblots, total 
Plk1 and active PLK1T210ph protein levels in asynchronous and 
Monastrol-arrested mitotic cells appeared to be unaffected in 
Mio-depleted cells (Fig. 6 F). It thus appears that the reduction 
in Plk1 protein levels and activity is restricted to centrosomes.
These results are consistent with the fact that Plk1 is acti-
vated at centrosomes during G2 by Aurora A complexed with its 
cofactor Bora (Macůrek et al., 2008; Seki et al., 2008).
Localization of HURP and MCAK is altered 
upon Mio depletion
Both Aurora A and Plk1 are regulatory kinases. We therefore 
sought to identify downstream effectors that might be re-
sponsible for the spindle and mitotic abnormalities observed 
after Mio depletion and the consequent loss of active Aurora 
A and Plk1 from centrosomes.
One likely target is HURP, whose binding to microtu-
bules is regulated by Aurora A phosphorylation (Yu et al., 
2005; Wong et al., 2008). HURP is part of a Ran-dependent 
complex required for chromatin-dependent microtubule nucle-
ation (Koffa et al., 2006; Silljé et al., 2006). In control RNAi 
cells, HURP was localized to spindle microtubules in a band 
transverse to the spindle axis that was maximal in the vicin-
ity of chromosomes. This localization is consistent with the 
regulation of HURP by Ran-GTP.
The distribution of HURP on the spindle was dramatically 
altered upon Mio depletion. The protein was then evenly dis-
tributed throughout the spindle, and the chromosome-proximal 
characteristic band was lost (Fig. 7 A). A similar mislocaliza-
tion of HURP was previously seen in cells treated with selec-
tive Aurora A inhibitors or depleted of the Aurora A–activating 
partner TPX2 (Kesisova et al., 2013).
This effect of Mio depletion on HURP appears to be quite 
specific. TPX2 is a partner of HURP in a complex that contrib-
utes to Ran-dependent bipolar spindle formation (Koffa et al., 
2006). No changes were observed in either localization or abun-
dance of TPX2 in Mio-depleted cells (Fig. S4, A and C). TPX2 
is an important activator of Aurora A (Kufer et al., 2002; Tsai 
et al., 2003; Özlü et al., 2005), and these observations therefore 
suggest that the decrease in the levels of active Aurora AT288ph is 
likely not due to altered TPX2 protein levels. Aurora A still inter-
acted with TPX2 after Mio depletion (Fig. S4 C). Kinase assays 
on TPX2–Aurora A complexes confirmed a reduction of Aurora 
A kinase activity toward TPX2 and histone H3 (Fig. S4 D).
Localization of a second important Aurora A substrate 
was also changed after Mio RNAi. MCAK is a microtubule-de-
polymerizing kinesin that has an essential role in chromosome 
segregation by controlling kinetochore–microtubule attach-
ments (Tanenbaum et al., 2011). MCAK is localized to inner 
centromeres, kinetochores, and spindle poles of mitotic cells, 
and its subcellular localization and activity are controlled by 
phosphorylation (Andrews et al., 2004). Importantly, the spin-
dle pole association of MCAK is dependent on Aurora A phos-
phorylation (Zhang et al., 2008).
The level of centrosomal MCAK was dramatically re-
duced in cells exposed to Mio RNAi (Fig. 7 B). In contrast, the 
pool of kinetochore-associated MCAK appeared unaffected by 
Mio depletion. In cells exposed to control RNAi, GFP-MCAK 
localized to both kinetochores and spindle poles as previ-
ously described (Fig. 7 B; Davis et al., 1983; Lane and Nigg, 
1996; Logarinho and Sunkel, 1998). The level of centrosomal 
MPM2 staining (Davis et al., 1983) was dramatically reduced 
in cells exposed to Mio RNAi (Fig. 7 C), confirming a reduc-
tion of Plk1 activity at the centrosomes (Lane and Nigg, 1996; 
Logarinho and Sunkel, 1998).
These effects of Mio depletion were specific for HURP 
and MCAK and were not a result of a general disruption of 
the centrosome. It has been suggested that Plk1 activity also 
contributes to centrosomal localization of the plus end–directed 
bipolar kinesin Eg5 before mitotic entry (Bertran et al., 2011; 
Smith et al., 2011). Eg5 localized normally to centrosomes in 
Mio-depleted cells (Fig. S4 B; Lane and Nigg, 1996). Thus, in-
terphase CDK and Plk1 activities in Mio-depleted cells are suf-
ficient to load Eg5 on centrosomes before mitotic entry (Davis 
et al., 1983; Logarinho and Sunkel, 1998).
NuMA, LGN, and the dynein–dynactin motor complex 
function at the cell cortex, where they help to generate pull-
ing forces on astral microtubules and direct spindle rotation 
(Woodard et al., 2010; Kiyomitsu and Cheeseman, 2012). Both 
NuMA and the dynactin subunit p150 localized normally to 
spindles and spindle poles in Mio-depleted cells (Fig. S5). 
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However, cortical levels of p150 were slightly increased near 
the spindle pole (Fig. S5 B). This was the exact opposite from 
the expected cortical p150 localization at the cortex furthest 
away from the pole. The above observation is consistent with 
the hypothesis that spindle pole–localized active Plk1 reg-
ulates dynactin complex dissociation from the cell cortex 
during spindle orientation.
Mitotic progression is impaired in the 
absence of the Mio Ring/PHD domain
Mio is highly conserved from yeast to mammals (Iida and 
Lilly, 2004). Its N-terminal domain contains several WD40 
repeats that are likely to be involved in protein–protein in-
teraction (Smith et al., 1999). Mio also has a C-terminal 
domain with a pattern of conserved histidine and cysteine 
Figure 5.  Mio-depleted cells show sensitivity to Plk1 and Aurora A inhibition. (A) Quantitation of monopolar spindles in control (dotted lines) and 
Mio-depleted cells (solid lines) 46 h after siRNA transfection followed by 1.5-h incubation into the indicated concentrations of ZM447439, BI2356, and 
MLN8237. (B) The difference (Δ) in monopolar spindle percentage between control and Mio-depleted cells at each indicated drug concentration. (C–E) 
Mitotic profile of control and Mio-depleted cells 48 h after siRNA transfection followed by 1.5-h incubation into the indicated concentrations of BI2356 (C), 
MLN8237 (D), and ZM447439 (E). (A–E) 300 cells per condition/drug concentration (n = 3). Error bars represent SD. The highlighted gray areas of the 
monopolar spindles mitotic stage are used for the graphs in A and B.
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Figure 6. Plk1 and Aurora A are misregulated after Mio depletion. (A) Control and Mio-depleted cells were fixed and immunostained with α–Aurora A 
(red), α-tubulin (green), and DNA (blue). Arrows point to centrosomes. (B) Control and Mio-depleted cells were fixed and immunostained with α-p–Aurora 
AT288 (green), α-tubulin (red), and DNA (blue). (C) Control and Mio-depleted cells were fixed and immunostained with α-Plk1 (red), α-tubulin (green), and 
DNA (blue). Arrows point to centrosomes. (D) Quantification of Aurora A and p–Aurora AT288 levels at spindle poles in control and Mio-depleted cells. 
Depletion of Mio reduces p–Aurora AT288 levels, whereas Aurora A is mostly retained. (E) Quantification graph of PLK1 and p-PLK1T210 levels at centrosomes 
in control and Mio-depleted cells. Both Plk1 and p-Plk1T120 levels at centrosomes are reduced. (D and E) Fluorescence intensities are in arbitrary units (AU). 
Error bars represent SD. (F and G) Immunoblots of HeLa cell lysates treated with siRNAs corresponding to negative control and Mio from asynchronous 
and Monastrol-arrested cells (probed using α-PLK1, α–p-PLK1T210, α–Aurora A, and α-p–Aurora AT288) show reduction of Aurora AT288ph signal upon Mio 
depletion, whereas total Aurora A, Plk1, and Plk1T210ph levels appear unchanged. Tubulin serves as a loading control. n.s., not significant. Bars, 10 µm.
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residues resembling a RING/PHD domain (Fig. 8 A). Such 
RING/PHD domains frequently mediate E3 ligase activity 
(Deshaies and Joazeiro, 2009). We used the Protein Ho-
mology/Analogy Recognition Engine version 2.0 (Phyre2) 
server (Kelley and Sternberg, 2009) to model Mio’s RING/
PHD domain structure on the crystal structure of Ring E3 
ubiquitin ligase RNF8 bound to a UBC13/MMS2 heterodi-
mer (Protein Data Bank accession no. 4ORH). Cysteine and 
histidine residues that are predicted to coordinate the two 
zinc atoms and help maintain the domain structure are high-
lighted (Fig. 8, A [red] and B [labels]). Based on this model, 
we decided to create two Mio mutants: a C-terminal RING/
PHD deletion (ΔPHD) missing the last 91 amino acids and a 
combination of eight specific point mutations (C785, C788, 
C830, H832, H835, H838, C849, and C854) that convert 
predicted zinc-binding cysteine and histidine residues to 
alanine. This would be predicted to disrupt the folding of 
the Ring domain (Fig. 8 B).
We performed rescue experiments to evaluate the im-
portance of the RING/PHD domain in mitotic progression 
(Fig. 8 C). These experiments also serve as overall controls 
showing that the delay in mitotic progression, observed after 
Mio depletion, is not due to off-target effects of the RNAi. 
Stable cell lines expressing siRNA-resistant wild-type or 
mutant Mio (si02ResGFP-MioWT, si02ResGFP-MioRING8A, and 
si02ResGFP-MioΔPHD) were depleted of endogenous Mio. The 
wild-type transgene efficiently rescued the increase in mi-
totic timing (Fig. 8 C) and the convoluted nuclear shape ob-
served upon Mio depletion. In contrast, neither the Ring8A 
nor ΔPHD mutants were able to fully rescue these pheno-
types. Thus, despite our inability to demonstrate an E3 ubiq-
uitin ligase activity for purified Mio (unpublished data), the 
Mio C-terminal RING/PHD region clearly is required for 
normal mitotic progression.
Active mTOR levels are reduced at 
centrosomes in mitotic cells upon 
Mio depletion
Mio is a highly conserved member of the SEACAT/GATOR2 
complex, antagonizing GATOR1, a known inhibitor of Rag-1 
GTPase, and hence promoting mTOR signaling (Bar-Peled 
et al., 2013; Panchaud et al., 2013a). We therefore decided 
to look directly at levels of active mTOR in cells after Mio 
depletion. Upon its activation, mTOR is phosphorylated on 
several sites, including Ser2481 (Peterson et al., 2000). mTOR 
Ser2481 autophosphorylation correlates with mTOR cata-
lytic activity (Soliman et al., 2010). Although levels of total 
mTOR appeared unaffected by Mio depletion (Fig. 9 C), lev-
els of active mTOR (mTORS2481ph) on centrosomes and spin-
dles were much lower in Mio-depleted cells than in control 
RNAi cells (Fig. 9, A and B).
We next examined phosphorylation of known mTORC1 
substrates as a direct measure of mTORC1 activity. Amino 
acid withdrawal leads to rapid mTORC1 inactivation (San-
cak et al., 2008). Mio depletion strongly inhibited the amino 
acid–induced activation of mTORC1 as monitored by levels 
of S6K1 and 4EBP1 phosphorylation (Fig. S4 F). Rescue 
experiments on HeLa si02ResGFP-Mio cells where only 
the endogenous Mio was depleted using si02 (si01 targets 
both endogenous and exogenous constructs) restored both 
mTORS2481ph levels at spindle poles and p70S6KT389ph phos-
phorylation (Fig. S4, E and F).
If Mio depletion disrupts mitotic progression by inhibit-
ing mTOR, activation of the kinase by an alternative pathway 
might be expected to at least partially rescue the Mio depletion 
phenotype. PTEN (phosphatase and tensin homologue) dephos-
phorylates phosphoinositide-3,4,5-triphosphate (PIP3), a po-
tent activator of AKT kinase signaling (Maehama and Dixon, 
1998). mTOR is a key downstream target of AKT (Sabatini, 
2006); thus, PTEN inactivation results in increased mTOR ac-
tivity. Co-depletion of Mio and PTEN showed a partial rescue 
of mitotic progression and increased Aurora AT288ph levels at 
spindle poles (Fig. 10, D–F).
Figure 7. Spindle assembly factors HURP and MCAK are misregulated 
after Mio depletion. (A) Control and Mio-depleted cells were fixed and 
immunostained with α-HURP (green), α-tubulin (red), and DNA (blue). 
(B) Control and Mio-depleted cells transfected with GFP-MCAK (green) 
were fixed and immunostained with α-pericentrin (red) and DNA (blue). 
(C) Control and Mio-depleted cells were fixed and immunostained with 
α-MPM2 (red), α-tubulin (green), and DNA (blue). Bars, 10 µm.
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To determine by independent method that inhibition 
of mTOR can explain the mitotic defects observed upon Mio 
depletion, we developed a protocol that enabled us to inhibit 
the kinase without blocking cell cycle progression. Rapamy-
cin, when bound to intracellular protein FKBP12, inhibits 
mTORC1 kinase activity (Guertin and Sabatini, 2009). Rapa-
mycin treatment for 4 h resulted in an increase of prometaphase 
cells that also showed a decrease of both Aurora and Aurora 
AT288ph levels at spindle poles (Fig. 10, G–I), reinforcing the 
idea that reduced mTORC1 activity causes the mitotic defects 
observed upon Mio depletion.
We conclude that Mio is required for maintenance of ac-
tive mTOR levels in mitosis.
Discussion
Mio is a component of the SEACAT/GATOR2 complex, which 
has been reported to be involved in mTOR regulation by the 
Rag-GTPase (Bar-Peled et al., 2013; Panchaud et al., 2013a). 
Here, we confirm that Mio interacts with Seh1, a member of 
the SEACAT/GATOR2 and Nup107 nucleoporin complexes, 
both in interphase and mitosis. Our experiments identified roles 
for Mio in timely mitotic progression, centrosome separation, 
spindle formation, and orientation/positioning in human mitotic 
cells. Indeed, 35% of mitotic cells observed after Mio depletion 
had a bipolar, monoastral structure (i.e., they lacked a centro-
some and astral microtubules at one of the two spindle poles). 
Figure 8. Mitotic progression is impaired in the 
absence of the Ring/PHD domain. (A) Schematic di-
agram showing the domain structure of Mio and the 
sequence of its C-terminal Ring/PHD domain. The pre-
dicted cysteines and histidines involved in zinc coordi-
nation are labeled in red. (B) Cartoon representation 
of predicted 3D molecular structure of Mio C-terminal 
Ring/PHD domain showing the mutated residues in 
stick form. Zinc ions are shown in ball representation 
(as white spheres). (C) Mitotic progression scatter 
plots with NEBD as T = 0 in control (blue), Mio siR-
NA-treated cells with and without (red) expression of 
siRNA-resistant versions of wild-type GFP-Mio (green), 
GFP-MioRing8A (black), and GFP-MioΔPHD (purple) from 
live cell videos. n = 214 cells from two independent 
experiments. Statistical significance was determined 
by an unpaired Student’s t test.
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Functional analysis revealed that Mio plays a critical role in 
activation of the essential mitotic kinases, Aurora A and Plk1, 
at spindle poles. We could find no role for Mio in NPC assem-
bly or structure, suggesting that the mitotic phenotypes of Mio 
depletion may reflect the loss of SEACAT/GATOR2 regulation 
of mTOR kinase signaling. Thus, our experiments reveal a pre-
viously unsuspected role for mTOR in mitotic regulation.
Centrosome separation and bipolar spindle formation 
both require Plk1 and Aurora A activity. Mio depletion caused 
a marked reduction of active Aurora AT288ph without changes in 
the localization or levels of total Aurora A or TPX2. Spindle 
length was normal after Mio depletion, which is consistent with 
the interaction between Aurora A and TPX2 being unaffected 
(Bird and Hyman, 2008) and suggesting that the reduction of 
Aurora AT288ph levels observed upon Mio depletion was not a 
result of the loss of TPX2-mediated activation. Despite the re-
duced activity of Aurora A and defects in centrosome separation 
after Mio depletion, bipolar spindle formation still occurred, 
possibly as a result of microtubule nucleation from chromo-
somes via the Ran-GTP pathway (Caudron et al., 2005; Kaláb 
et al., 2006; Kalab and Heald, 2008).
Aurora A activates centrosomal Plk1 through phosphor-
ylation of Thr210 (Macůrek et al., 2008; Seki et al., 2008; 
Carmena, 2012; Bruinsma et al., 2014). Active Plk1 controls 
entry into mitosis and also promotes centrosome maturation 
and separation (Bruinsma et al., 2012; Zitouni et al., 2014). 
Plk1 localization influences its activity and vice versa (Kishi et 
al., 2009). Upon Mio depletion, levels of total Plk1 and active 
Plk1T210ph were reduced at centrosomes. As a result, Mio-de-
pleted cells were hypersensitive to Plk1 inhibition as detected 
by synthetic interaction with the Plk1 inhibitor BI2536, result-
ing in an increase in monopolar spindles even at low drug con-
centrations. The reduction in active Plk1 levels in Mio-depleted 
cells may result in a partial inhibition of mitotic entry and may 
explain the apparent paradox that Mio-depleted cells exhibit a 
substantial delay in mitotic progression without an accompany-
ing increase in mitotic index.
Mio depletion from HeLa cells causes multiple mitotic 
defects such as a lengthening of the interval between NEBD 
and anaphase onset, spindle assembly defects including an 
increase in the number of bipolar monoastral spindles, a pro-
metaphase delay often associated with monopolar spindles, 
and a delay or failure in cytokinesis. Interestingly, in Dro-
sophila melanogaster, where Mio has been reported to play a 
role in oocyte maturation, the microtubule-dependent translo-
cation of centrioles from the anterior to the posterior of stage 
1 oocyte nuclei is defective, as is the microtubule-dependent 
translocation of RNA-binding protein Orb (Iida and Lilly, 
2004). Thus, the involvement of Mio with microtubule func-
tion is conserved across species.
Aurora A regulates mitotic spindle formation at least 
partially as part of a multiprotein subunit complex containing 
HURP, TPX2, and Eg5 kinesin (Koffa et al., 2006). HURP is 
a microtubule stabilizer (Silljé et al., 2006; Santarella et al., 
2007) that localizes mainly to kinetochore microtubules and 
requires Aurora A phosphorylation for its microtubule binding 
(Yu et al., 2005; Wong et al., 2008). TPX2 binds to and activates 
Aurora A on the mitotic spindle (Kufer et al., 2002; Giubettini 
et al., 2011). Eg5 is required for centrosome separation after 
NEBD (Kapitein et al., 2005; Smith et al., 2011; Mardin and 
Schiebel, 2012). Our analysis of mitotic spindles after Mio de-
pletion showed a dramatic change in HURP localization, with 
the protein spreading throughout the spindle, as previously seen 
upon Aurora A kinase inhibition (Kesisova et al., 2013). Indeed, 
we observed a decrease in Aurora A activation (detected as a 
decrease in Aurora A phosphorylated on its activation loop at 
Figure 9. Activity of mTOR is reduced in mitotic cells after Mio depletion. 
(A) Control and Mio-depleted cells were fixed and immunostained with 
α–p-mTOR (Ser2481; green), α-tubulin (red), and DNA (blue). (B) Con-
trol and Mio-depleted cells were fixed and immunostained with α–p-mTOR 
(Ser2481; green), γ-tubulin (red), and DNA (blue). (C) Control and Mio-de-
pleted cells were fixed and immunostained with α-mTOR (green), α-tubulin 
(red), and DNA (blue). Bars, 10 µm.
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Figure 10. Activity of mTOR is reduced in mitotic cells after Mio depletion. (A) Quantification of p–Aurora AT288 levels at spindle poles in control, Mio-de-
pleted, and Mio/PPP6C co-depleted cells. (B) Mitotic profile of control, Mio-depleted, and Mio/PPP6C co-depleted cells 48 h after siRNA transfection. 300 
cells per condition (n = 3). (C and F) Immunoblots of HeLa cell lysates treated with siRNAs corresponding to negative control, Mio, Mio with PPP6C, PTEN, 
and Mio/PTEN from asynchronous cells (probed using α-Mio, α-PPP6C, and α-PTEN) show efficient depletion of Mio, PPP6C, and PTEN. Tubulin serves as 
a loading control. (D) Quantification of Aurora A and p–Aurora AT288 levels at spindle poles in control, Mio-depleted, and Mio/PTEN co-depleted cells. 
PTEN co-depletion with Mio rescues the p–Aurora AT288 levels reduction. (E) Mitotic profile of control, Mio-depleted, and Mio and PTEN co-depleted cells 
48 h after siRNA transfection. 300 cells per condition (n = 3). (G) Quantification of Aurora A and p–Aurora AT288 levels at spindle poles in control DMSO- 
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Thr288) on Mio-depleted mitotic spindles. Eg5 and TPX2 lo-
calization, on the other hand, appeared to be unaffected. Thus, 
defects in Eg5 localization to centrosomes and microtubules are 
unlikely to explain the bipolar, monoastral spindles observed in 
35% of Mio-depleted mitotic cells.
The kinesin-13 family microtubule depolymerase MCAK 
associates with centromeres and growing microtubule ends, 
where it plays a role in correction of kinetochore–microtubule 
misattachments from prophase to anaphase. MCAK also local-
izes to spindle poles, where it is required for the assembly and 
dynamics of the mitotic spindle. MCAK localization at the cen-
tromere and its depolymerase activity are regulated by Aurora 
B (Andrews et al., 2004; Kline-Smith et al., 2004; Lan et al., 
2004; Knowlton et al., 2006). In contrast, MCAK localization at 
the poles is regulated by Aurora A activity (Zhang et al., 2008). 
In Mio-depleted cells, we observed a reduction of MCAK local-
ization at the poles, whereas MCAK’s centromeric localization 
appeared to be unaffected. Interference with MCAK activity 
specifically at centrosomes could partly explain the spindle as-
sembly defects observed upon Mio depletion.
mTOR plays key roles in several cellular processes 
through interactions with other proteins to form mTOR 
complexes 1 and 2 (mTORC1/2). mTORC1 positively reg-
ulates cell growth, proliferation, and the cell cycle, whereas 
mTORC2 plays key roles in cell survival, metabolism, and 
actin organization (Laplante and Sabatini, 2009; Wang and 
Proud, 2011). Recent studies have suggested a link between 
mTORC1 and mitosis. mTORC1 complex components have 
been shown to associate with mitotic spindles in mouse oo-
cytes (Kogasaka et al., 2013), and overexpression of mTORC1 
results in impairment of spindle formation and aneuploidy 
(Astrinidis et al., 2006). In yeast, Aurora A promotes cell di-
vision during recovery from mTOR-mediated cell cycle ar-
rest by driving spindle pole body recruitment of Polo (Hálová 
and Petersen, 2011), while at the same time overexpression 
of Plk1 increases the phosphorylation of mTORC1 substrates 
(Renner et al., 2010), suggesting the existence of a molecular 
and functional link between Plk1 mitotic kinase, mTOR sig-
naling, and spindle formation.
Here, we show for the first time that mTORC1 is an 
important regulator of mitotic spindle assembly. Our results 
reveal a link between Mio and SEACAT/GATOR2 complex 
(Bar-Peled et al., 2013; Panchaud et al., 2013a) regulation of 
mTORC1 kinase and the spatiotemporal activation of Aurora 
A and Plk1 at centrosomes during mitosis. The function of 
Mio in the SEACAT/GATOR2 complex is not known. Al-
though we have been unable to confirm any E3 enzymatic ac-
tivity for purified Mio in vitro, the presence of a RING/PHD 
domain in Mio suggests that the protein might control the 
stability/interaction of key components of the mTOR signal-
ing pathway. Indeed, the inability of Mio RING/PHD domain 
mutants to rescue mitotic progression suggests that the RING/
PHD domain does play a role in Mio function during mitosis. 
Future studies will focus on the role of Mio in the SEACAT/
GATOR2 complex and the mechanisms by which this com-
plex links mTOR signaling to the regulation of Aurora A and 
Plk1 at mitotic centrosomes.
Materials and methods
Cell culture
HeLa Kyoto cells were grown in DMEM supplemented with 10% FCS, 
0.2 mM l-glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin. 
Cell lines stably expressing EGFP-Mio, EGFP-Mio Ring mutant, and EG-
FP-Mio-ΔPHD were generated using the HeLa Flp-In cell line (Klebig 
et al., 2009) and Flp-in system vectors (Invitrogen) and were maintained 
in the aforementioned media with an additional 200 µg/ml hygromycin.
The HeLaEGFP-H2B Kyoto cell line was generated by transfecting 
human H2B coding sequence fused to 3′ of EGFP (Takara Bio Inc.) 
to HeLa Kyoto cells and was maintained in G418 (EGFP-Seh1 cDNA 
were previously described [Platani et al., 2009]), and the HeLa Kyo-
tomRFP-H2B GFP-tubulin cell line was generated for this study by transfect-
ing mRFP-H2B and GFP–α-tubulin cDNA to HeLa Kyoto cell lines 
and was maintained in G418.
RNAi and transfection experiments
cDNA transfections were performed using X-treme Gene (Roche). 
RNAi experiments were performed using annealed siRNA oligos 
(Ambion and QIAGEN) using HiPerFect reagent (QIAGEN). Full se-
quences of siRNA oligos are provided in Table S1.
Microscopy and image analysis
For immunofluorescence, 3D datasets were acquired using a camera 
(CoolSnap HQ cooled CCD; Photometrics) on a microscope (Delta-
Vision Spectris; Applied Precision). Optical sections were acquired 
every 0.2 µm, and 3D datasets were deconvolved using the constrained 
iterative algorithm (Swedlow et al., 1997; Wallace et al., 2001) imple-
mented in the SoftWoRx software (Applied Precision). For live cell 
imaging, cells were grown on glass-bottomed Lab-Tek dishes (Thermo 
Fisher Scientific), transfected with appropriate siRNAs, and main-
tained in a humidified 37°C chamber in a CO2-independent phenol 
red–free DMEM (Invitrogen). Images were collected using a 100×/1.4 
NA PlanApo objective lens with optical sections every 0.5 µm and a 
20×/0.4 PlanFL Ph1 objective. Images were loaded into Photoshop 
(Adobe) or OMERO (Open Microscopy Environment) and adjusted for 
display (Allan et al., 2012).
Quantification of Plk1 and p-Plk1 on ∼80 cells per condition was 
performed as follows: deconvolved images were imported into OMERO 
(Swedlow et al., 2009), and segmentation of centrosomal foci (pericen-
trin FITC, reference channel) was performed using the Otsu method, 
implemented in Matlab (MathWorks). These segmentation masks were 
then used to calculate intensities for these bodies in Plk1 and p-Plk1 
channels, and output was imported into Excel (Microsoft) for plotting. 
Signal within these volumes was quantified, background corrected, and 
represented as mean fluorescent intensity/pixel. Quantification of Au-
rora A and P–Aurora A on ∼210 cells per condition was performed 
directly on their respective channel. That is, deconvolved images were 
imported into OMERO, and Otsu segmentation of the spindle and cen-
trosomal signal was performed on the FITC channel (Aurora A and 
P–Aurora A) staining. The signal within these volumes was quantified, 
background corrected, and represented as fluorescence intensity/pixel.
cDNAs, antibodies, and immunofluorescence
All fixation, permeabilization, and immunostaining were performed 
at room temperature. Cells grown on coverslips were fixed in a 3.7% 
and rapamycin-treated cells. (A, D, and G) Fluorescence intensities are in arbitrary units (AU). (H) Control DMSO- and rapamycin-treated cells were fixed 
and immunostained with α-pericentrin (green), α-tubulin (red), and DNA (blue). (I) Mitotic profile of control DMSO- and rapamycin-treated cells after 4-h 
incubation ( n = 3). Error bars represent SD. n.s., not significant. Bar, 10 µm.
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formaldehyde/PBS solution for 10 min and permeabilized in PBS–
0.5% Triton X-100 for 10 min. Cells were blocked in 10% normal don-
key serum for 1 h at room temperature before antibody incubations. 
For γ-tubulin staining, cells were fixed in 100% methanol for 10 min 
and rehydrated in PBS for 20 min before staining. For Bub1, MPM2, 
and Sgo1 staining, a prepermeabilization step with 0.1% Triton X-100 
in Pipes-Hepes-EGTA-MgCl2 buffer for 1 min was included followed 
by PFA fixation. Antibodies used in this study are listed as follows. 
Antibody against human Mio was raised in rabbits against the C-ter-
minal part of the protein corresponding to amino acids 720–876 ex-
pressed as a His-tagged protein. The antibody was purified from serum 
using the corresponding protein immobilized on Affigel beads (Bio-
Rad Laboratories). The other antibodies used are tyrosinated tubulin 
YL12 (rat; Abcam), α-tubulin (mouse, DMIA; Sigma-Aldrich), PLK1 
(mouse; EMD Millipore), p-Plk1T210 (mouse; Abcam), Aurora A 
(mouse; BD), P–Aurora A T288 (rabbit; Abcam), Eg5 (rabbit; Novus 
Biologicals), GFP (rabbit; Life Technologies), ACA (human; Anti-
bodies Incorporated), mAb414 (mouse; Covance), pericentrin (rabbit; 
Abcam), γ-tubulin (mouse; Sigma-Aldrich), Hurp (rabbit; Abcam), 
Numa (rabbit; Abcam), TPX2 (mouse; Abcam), p150 (mouse; BD), 
Aurora B (rabbit; Abcam), Survivin (rabbit; Novus Biologicals), Bub1 
(mouse; Abcam), Sgo1 (mouse; Abcam), mTOR and p-mTOR2481 
(rabbit; Cell Signaling Technology), p70S6K (Thr389, antibody kit, 
rabbit; Cell Signaling Technology), PTEN (rabbit, D4.3; Cell Signal-
ing Technology), 4EBP1 (53H11, rabbit; Cell Signaling Technology), 
4EBP1 (Ser65, rabbit; Cell Signaling Technology), MPM2 (mouse; 
EMD Millipore), PPP6C (rabbit; Bethyl Laboratories, Inc.), SAPK/
JNK (56G8, rabbit; Cell Signaling Technology), SAPK/JNK (Thr183/
Tyr185, rabbit; Cell Signaling Technology), p38 MAPK (D13E1, rab-
bit; Cell Signaling Technology), p38 MAPK (Thr180/Tyr182; rabbit, 
Cell Signaling Technology), p44/42 MAPK and p44/42 Thr202/Tyr204 
(137F5, rabbit; Cell Signaling Technology), and Seh1 (rabbit, gener-
ated against full-length histidine-tagged human protein; Platani et al., 
2009). All affinity-purified donkey secondary antibodies (labeled ei-
ther with FITC, Alexa Fluor 488, TRITC, Alexa Fluor 594, or Cy5) 
were purchased from Jackson ImmunoResearch Laboratories, Inc. Per-
oxidase-conjugated donkey anti–rabbit and goat anti–mouse antibod-
ies were purchased from Roche.
Monastrol (EMD Millipore) was used at 100 µM. ZM447439 
(Tocris Bioscience) was used at 0.5, 1, and 2 µM; MLN8237 (Selleck-
chem) was used at 10, 50, and 300 nM; BI2356 (Selleckchem) was 
used at 25, 50, and 100 nM for 1.5 h; and rapamycin (Sigma-Aldrich) 
was used at 200 nM for 4 h followed by recovery in normal medium.
For spindle length measurements, cells were stained with cen-
tromeric marker (ACA) to identify clear metaphase plates and cen-
trosome marker (pericentrin). Pole to pole measurements were made 
from single sections of 3D datasets using OMERO. Only spindles 
parallel to the plane of focus were used to avoid artifacts that can 
be created by spindle rotation into the plane of focus. Spindle ro-
tation measurements of the metaphase spindle with respect to the 
fibronectin substratum were performed as previously described (Toy-
oshima and Nishida, 2007). In brief, cells that showed a congressed 
metaphase plate were stained with γ-tubulin or pericentrin to mark 
the poles and Hoechst 33342 to mark DNA. Stacks of 3D images at 
0.2-µm steps were acquired, and the poles’ distances in X, Y, and Z 
were determined using OMERO. The spindle angle was calculated 
using inverse trigonometry.
For analysis of cold-stable microtubules, cells were incubated in 
ice-cold media for 10 min before incubation in ice-cold Pipes-Hepes-
EGTA-MgCl2 buffer/0.5% Triton X-100 for 2 min. Fixation was per-
formed in ice-cold methanol for 2 min, followed by washing with PBS 
twice and final rehydration in fresh PBS for 15 min.
Mammalian expression plasmids of EGFP-Mio, EGFP-
Mio-ΔPHD (1–2,353 bp), and Cherry-Mio were cloned using pEG-
FP-C1 and mCherry-C1 vectors. Mio cDNA was amplified with 
Phusion polymerase (New England Biolabs, Inc.) from total HeLa 
RNA extracted with TRIzol (Invitrogen). Site-directed mutagenesis 
was performed using the QuikChange XL system (Agilent Technolo-
gies) according to the manufacturer’s protocol.
siRNA-resistant GFP-Mio, GFP-Mio-Ring mutant, and GFP-
Mio-ΔPHD cDNA was generated by site-directed mutagenesis carrying 
silent nucleotide mutations (in bold letters: 5′-GCCGCGACCTTGC-
TATCCATA-3′) at positions 150, 153, 156, 159, 162, and 165, respectively.
Isolation of mCherry-Mio
mCherry and mCherry-Mio complexes were isolated from 3 × 10–cm 
dishes of asynchronous HeLa Kyoto cells 28 h after transfection with the 
corresponding cDNA constructs. Cells were washed twice in ice-cold 
PBS and collected and lysed in 0.6 ml lysis buffer (50 mM Tris, pH 7.5, 
150 mM NaCl, 0.5% NP-40, and protease inhibitors). Extracts were left 
on ice for 30 min before centrifugation at 20,000 g for 10 min at 4°C. 
Equilibrated RFP trap beads (ChromoTek) were added to cleared cell 
lysates and rotated at 4°C for 2 h. The beads were washed four times 
with wash buffer (50 mM Tris, pH 7.5, 150 mM NaCl, and 0.05% NP-
40) before sample buffer addition, SDS-PAGE, and Western blotting.
Isolation of Aurora A–TPX2 complexes and kinase assays
Aurora A–TPX2 complexes were isolated from 6 × 10–cm dishes of 
HeLa cells at ∼60–70% confluency as described in Zeng et al. (2010). 
In brief, cells were arrested in mitosis with 100 ng/ml nocodazole for 
16 h, lysed in 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton 
X-100, protease inhibitors, and phosphatase inhibitor cocktail 2 (Sig-
ma-Aldrich), and left on ice for 30 min before centrifugation at 20,000 
g for 20 min at 4°C. Equilibrated protein G–Sepharose beads (GE 
Healthcare) together with either 2 µg of control mouse IgG or TPX2 
antibody were added to the cell lysates and rotated at 4°C for 2 h. The 
beads were washed in lysis buffer and TBS before sample buffer ad-
dition, SDS-PAGE, and Western blotting. For in vitro kinase assays, 
isolated Aurora A–TPX2 complexes were incubated for 30 min at 30°C 
in a 20-µl solution of 50 mM Tris-HCl, pH 7.4, 50 mM KCl, 10 mM 
MgCl2, 20 mM β-glycerolphosphate, 15 mM EGTA, 100 µM ATP, 0.5 
µl γ-[32P]ATP solution, and 1 µg Histone H3 substrate (New England 
Biolabs, Inc.) before the addition of sample buffer. Reactions were an-
alyzed by SDS-PAGE and autoradiography.
Amino acid starvation and stimulation
HeLa cells grown in RPMI were washed in PBS, and starvation was 
performed by incubating the cells for 50–60 min in amino acid–free 
RPMI without serum. Cells were then stimulated for 20 min by the ad-
dition of RPMI containing a 2× concentrated solution of amino acids. 
After stimulation, the final concentration of amino acids in the media 
was the same as in the original RPMI medium.
Mass spectrometry
For Seh1 interactome mapping in interphase and mitosis by quantita-
tive affinity purification/mass spectrometry, 10 × 15–cm dishes of cells 
were differentially encoded by growth in SILAC DMEM supplemented 
with 10% dialyzed FBS and 100 U/ml penicillin/streptomycin and con-
taining either ”light” l-arginine and l-lysine (HeLaGFP), “medium” 
l-arginine–13C and l-lysine 4,4,5,5-D4 (HeLaGFP-Seh1/interphase), 
or “heavy” l-arginine–13C/15N and l-lysine–13C/15N (HeLaGFP-Seh1/
mitosis) for 7 d. Equal protein amounts of whole cell extract were 
incubated with GFP-TrapA (ChromoTek) affinity resin for 1 h at 4°C, 
the beads were washed in ice-cold radio immunoprecipitation assay 
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buffer and combined, and the proteins were eluted for gel separation, 
trypsin digestion, and liquid chromatography–tandem mass spectrom-
etry analysis on a mass spectrometer system (LTQ-Orbitrap; Thermo-
Electron) as previously described (Prévost et al., 2013). In brief, for 
efficient elution of bound proteins, a bead equivalent volume of 1% 
SDS was added, heated at 95°C for 10 min, and then a 4× volume of 
dH2O was added. The matrix was mixed, and the solution was removed 
and reduced to the original bead-equivalent volume using a speedvac. 
Proteins were reduced and alkylated by the addition of 10 mM DTT at 
95°C for 2 min followed by the addition of 50 mM iodoacetamide at 
room temperature for 30 min. Sample buffer was added, and proteins 
were separated on 10% Bis-Tris gels. Gels were Coomassie stained 
and destained overnight before excision of 10 gel slices. Peptides re-
sulting from in-gel digestion with trypsin (Promega) were extracted 
from the gel slices. An aliquot of each tryptic digest was analyzed by 
liquid chromatography–electrospray ionization–tandem mass spectrom-
etry on a mass spectrometer with a nanospray source (LTQ Orbitrap 
XL hybrid; Thermo Fisher Scientific) and an HPLC (UltiMate 3000 
RSLC nano; Dionex). The system was controlled by Xcalibur software 
version 2.0.7 (Thermo Fisher Scientific). Peptides were loaded onto 
a trap column (C18 CapTrap; Michrom) for 5 min at 15 µl/min and 
then were eluted over a 60-min gradient of 3–45% acetonitrile with 
0.1% formic acid at 0.3 µl/min onto a 10-cm column with integrated 
emitter tip (Picofrit; New Objective) packed with 5 µm Zorbax SBC18 
(Agilent Technologies) and nanosprayed into the mass spectrometer. 
Mass spectrometry scans were acquired in the Orbitrap module, and 
MS2 scans were acquired in the ion trap module using data-dependent 
acquisition of the top five ions from each MS scan. Database searching 
against the human UniProt database and quantitation were performed 
using MaxQuant version 1.2.7. Protein groups and peptide lists were 
analyzed in Excel (Microsoft).
Mio 3D structure prediction
The modeling of the Mio protein C-terminal sequence was performed 
using Phyre2 (Kelley and Sternberg, 2009). The predicted 3D mo-
lecular structure model of the Mio protein C-terminal sequence was 
created using a molecular visualization program (PyMOL version 
1.5.0.4; Schrödinger, LLC).
Statistical analysis
To assess statistical significance, we determined the t test for 
equal or unequal variances. A p-value of <0.05 was considered to 
be statistically significant.
Online supplemental material
Fig. S1 shows Seh1 interactome and rescue experiments using wild-
type GFP-Mio. Figs. S2 and S3 show that spindle assembly check-
points or centromeric localization of chromosome passenger complex 
are not affected after Mio depletion. Micrographs of cold-stable mi-
crotubule assays are also included. Fig. S4 shows spindle assembly 
factors TPX2 and Eg5 localization together with Aurora A kinase as-
says on Aurora A–TPX2 complexes after Mio depletion. Fig. S5 shows 
Numa and p150 spindle localization together with p-Plk1 localization. 
Table S1 contains a list of siRNA duplexes used in this study. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.201410001/DC1. Additional data are available in the JCB Dat-
aViewer at http://dx.doi.org/10.1083/jcb.201410001.dv.
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